Annual Total Liabilities
$62.07 M
+$13.89 M+28.83%
December 31, 2023
Summary
- As of February 20, 2025, CSTL annual total liabilities is $62.07 million, with the most recent change of +$13.89 million (+28.83%) on December 31, 2023.
- During the last 3 years, CSTL annual total liabilities has risen by +$38.43 million (+162.60%).
- CSTL annual total liabilities is now at all-time high.
Performance
CSTL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$73.51 M
+$10.09 M+15.91%
September 30, 2024
Summary
- As of February 20, 2025, CSTL quarterly total liabilities is $73.51 million, with the most recent change of +$10.09 million (+15.91%) on September 30, 2024.
- Over the past year, CSTL quarterly total liabilities has increased by +$11.44 million (+18.43%).
- CSTL quarterly total liabilities is now at all-time high.
Performance
CSTL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CSTL Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.8% | +18.4% |
| 3 y3 years | +162.6% | +18.4% |
| 5 y5 years | +91.1% | +18.4% |
CSTL Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.8% | at high | +100.2% |
| 5 y | 5-year | at high | +162.6% | at high | +292.2% |
| alltime | all time | at high | +162.6% | at high | +292.2% |
Castle Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.51 M(+15.9%) |
| Jun 2024 | - | $63.42 M(+13.2%) |
| Mar 2024 | - | $56.05 M(-9.7%) |
| Dec 2023 | $62.07 M(+28.8%) | $62.07 M(+23.6%) |
| Sep 2023 | - | $50.24 M(+7.7%) |
| Jun 2023 | - | $46.63 M(+11.7%) |
| Mar 2023 | - | $41.74 M(-13.4%) |
| Dec 2022 | $48.18 M(-5.2%) | $48.18 M(+3.9%) |
| Sep 2022 | - | $46.38 M(+26.3%) |
| Jun 2022 | - | $36.72 M(-22.0%) |
| Mar 2022 | - | $47.09 M(-7.4%) |
| Dec 2021 | $50.83 M | $50.83 M(+131.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $21.98 M(+12.0%) |
| Jun 2021 | - | $19.62 M(+4.7%) |
| Mar 2021 | - | $18.75 M(-20.7%) |
| Dec 2020 | $23.64 M(-31.8%) | $23.64 M(-46.1%) |
| Sep 2020 | - | $43.84 M(-0.2%) |
| Jun 2020 | - | $43.92 M(+35.9%) |
| Mar 2020 | - | $32.32 M(-6.7%) |
| Dec 2019 | $34.63 M(+6.6%) | $34.63 M(+12.2%) |
| Sep 2019 | - | $30.86 M(-16.5%) |
| Jun 2019 | - | $36.94 M(+27.5%) |
| Mar 2019 | - | $28.96 M(-10.8%) |
| Dec 2018 | $32.48 M(+34.8%) | $32.48 M |
| Dec 2017 | $24.09 M | - |
FAQ
- What is Castle Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Castle Biosciences?
- What is Castle Biosciences annual total liabilities year-on-year change?
- What is Castle Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Castle Biosciences?
- What is Castle Biosciences quarterly total liabilities year-on-year change?
What is Castle Biosciences annual total liabilities?
The current annual total liabilities of CSTL is $62.07 M
What is the all time high annual total liabilities for Castle Biosciences?
Castle Biosciences all-time high annual total liabilities is $62.07 M
What is Castle Biosciences annual total liabilities year-on-year change?
Over the past year, CSTL annual total liabilities has changed by +$13.89 M (+28.83%)
What is Castle Biosciences quarterly total liabilities?
The current quarterly total liabilities of CSTL is $73.51 M
What is the all time high quarterly total liabilities for Castle Biosciences?
Castle Biosciences all-time high quarterly total liabilities is $73.51 M
What is Castle Biosciences quarterly total liabilities year-on-year change?
Over the past year, CSTL quarterly total liabilities has changed by +$11.44 M (+18.43%)